Home » Topics » BioWorld Science

BioWorld Science
RSS

Kyoto University, Astellas present CDK8/CDK19 dual inhibitors

Aug. 23, 2018

Ancureall Biomedical Technology divulges histone-lysine N-methyltransferase EZH2 inhibitors

Aug. 23, 2018

Sichuan University describes inhibitors of mutant FLT-3 kinase

Aug. 23, 2018

Cathepsin S inhibitors discovered at Astellas

Aug. 23, 2018

NEU-4438: an advanced lapatinib-derived lead compound against trypanosomiasis

Aug. 23, 2018

Genentech describes discovery of a highly potent SERD for treatment of cancer

Aug. 23, 2018

VBX-100 demonstrates positive safety data in vitro

Aug. 23, 2018

DSMB reaffirms its recommendation to continue the phase II XanADu study

Aug. 23, 2018

Xintela announced progress in its development programs

Aug. 23, 2018

Theralase seeks Canadian clearances for phase II study of TLD-1433 in bladder cancer

Aug. 23, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...